BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 34990423)

  • 41. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
    Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
    Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
    Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
    Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY; Lee SM; Park JS; Kim HJ; Choi GS
    Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of Pathologic Complete Response for Rectal Cancer Based on Pretreatment Factors Using Machine Learning.
    Chen KA; Goffredo P; Butler LR; Joisa CU; Guillem JG; Gomez SM; Kapadia MR
    Dis Colon Rectum; 2024 Mar; 67(3):387-397. PubMed ID: 37994445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
    Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
    Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-Intensified Infliximab Rescue Therapy for Severe Ulcerative Colitis Does Not Reduce Short-term Colectomy Rates or Increase Postoperative Complications.
    Kosaraju RS; Wong DJ; Roth EM; Cataldo TE; Fabrizio AC; Crowell KT; Feuerstein JD; Messaris E
    Dis Colon Rectum; 2022 Oct; 65(10):1232-1240. PubMed ID: 35714346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.
    Fang C; Nie P; Jing P; Zhang Y; Yang L; Yu Y; Wang C; Zhou Z
    Dis Colon Rectum; 2021 Jun; 64(6):689-696. PubMed ID: 33394777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
    Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
    Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal Analysis of Local Recurrence and Survival After Transanal Abdominal Transanal Radical Proctosigmoidectomy for Low Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Marks JH; Reif de Paula T; Saidi H; Ikner TP; Schoonyoung H; Marks G; Keller DS
    Dis Colon Rectum; 2024 Mar; 67(3):377-386. PubMed ID: 38064243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
    Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
    Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guideline-Recommended Chemoradiation for Patients With Rectal Cancer at Large Hospitals: A Trend in the Right Direction.
    Del Vecchio NJ; Schlichting JA; Chioreso C; Kahl AR; Hrabe JE; Lynch CF; West MM; Charlton ME
    Dis Colon Rectum; 2019 Oct; 62(10):1186-1194. PubMed ID: 31490827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
    Williams H; Thompson HM; Lin ST; Verheij FS; Omer DM; Qin LX; Garcia-Aguilar J;
    Dis Colon Rectum; 2024 Mar; 67(3):369-376. PubMed ID: 38039292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management.
    Lukovic J; Kim JJ; Liu ZA; Cummings BJ; Brierley JD; Wong RKS; Ringash JG; Dawson LA; Barry A; Krzyzanowska MK; Chen EX; Hedley DW; Quereshy FA; Swallow CJ; Gryfe RN; Kennedy ED; Easson AM; Hosni A
    Dis Colon Rectum; 2022 Feb; 65(2):189-197. PubMed ID: 34990422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiologic Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer After Lateral Pelvic Lymph Node Dissection.
    Shiraishi T; Sasaki T; Tsukada Y; Ikeda K; Nishizawa Y; Ito M
    Dis Colon Rectum; 2021 Dec; 64(12):1479-1487. PubMed ID: 34657076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omentoplasty in Patients Undergoing Abdominoperineal Resection After Long-Course Chemoradiation for Locally Advanced and Locally Recurrent Rectal Cancer: A Comparative Single-Institution Cohort Study.
    van Campenhout I; van Rees JM; Ceelen W; Tanis PJ; Rothbarth J; Verhoef C
    Dis Colon Rectum; 2023 Jul; 66(7):994-1002. PubMed ID: 36574322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Value of the Circumferential Resection Margin After Curative Surgery for Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
    Galvez A; Biondo S; Trenti L; Espin E; Kraft M; Farres R; Codina-Cazador A; Flor B; Garcia-Granero E; Enriquez-Navascues JM; Borda-Arrizabalaga N; Kreisler E
    Dis Colon Rectum; 2023 Jul; 66(7):887-897. PubMed ID: 35348529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.